» Articles » PMID: 7121707

Lithium: Effect on [3H]spiperone Binding, Ionic Content, and Amino Acid Levels in the Brain of Rats

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 1982 Feb 1
PMID 7121707
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

After prolonged treatment of rats with lithium (pellets, 0.21% lithium carbonate, or 0.5 mg/ml lithium chloride in drinking water) for three months, the level of lithium in plasma was 0.87 meq/liter; in several brain regions, between 1.06-1.39 mueq/g wet weight. The content of sodium and potassium inthe plasma was normal. The level of potassium in the brain regions tested increased by 13-30% and that of sodium by about 10%. Glycine levels increased significantly in all the regions (cerebral cortex, midbrain, cerebellum, and spinal cord). In the cerebellum GABA was also increased, while glutamine was decreased. In midbrain, apart from increases in glycine levels, alanine, valine, GABA and lysine were also increased. In the spinal cord, glutamic acid was also increased. Changes were largely in the putative neurotransmitters. Long-term treatment with lithium also influenced the high-affinity binding of [3H] spiperone in the cerebral cortex and corpus striatum. Two specific binding sites were found in both brain regions; the main change was the reduction in the lower affinity binding site (B max 2).

Citing Articles

The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.

Pittman K, JAKUBOVIC A, Fibiger H Psychopharmacology (Berl). 1984; 82(4):371-7.

PMID: 6427831 DOI: 10.1007/BF00427688.


Dietary lithium during development: changes in amino acid levels, ionic content, and [3H]spiperone binding in the brain of rats.

Wajda I, Banay-Schwartz M, de Guzman T, Manigault I Neurochem Res. 1983; 8(5):637-48.

PMID: 6412150 DOI: 10.1007/BF00964703.


Acute and chronic effects of lithium chloride on GABA-ergic function in the rat corpus striatum and frontal cerebral cortex.

Otero Losada M, Rubio M Naunyn Schmiedebergs Arch Pharmacol. 1986; 332(2):169-72.

PMID: 3010141 DOI: 10.1007/BF00511408.


Modulation of the serotonin S2-receptor in brain after chronic lithium.

Wajda I, Banay-Schwartz M, Manigault I, Lajtha A Neurochem Res. 1986; 11(7):949-57.

PMID: 2944024 DOI: 10.1007/BF00965585.


Chronic lithium treatment and status epilepticus induced by lithium and pilocarpine cause selective changes of amino acid concentrations in rat brain regions.

Jope R, Miller J, Ferraro T, Hare T Neurochem Res. 1989; 14(9):829-34.

PMID: 2594148 DOI: 10.1007/BF00964811.

References
1.
Pert A, Rosenblatt J, Sivit C, Pert C, Bunney Jr W . Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science. 1978; 201(4351):171-3. DOI: 10.1126/science.566468. View

2.
Spring G . Neurotoxicity with combined use of lithium and thioridazine. J Clin Psychiatry. 1979; 40(3):135-8. View

3.
Rosenblatt J, Pert A, Layton B, Bunney Jr W . Chronic lithium reduces [3H]spiroperidol binding in rat striatum. Eur J Pharmacol. 1980; 67(2-3):321-2. DOI: 10.1016/0014-2999(80)90517-8. View

4.
Maggi A, Enna S . Regional alterations in rat brain neurotransmitter systems following chronic lithium treatment. J Neurochem. 1980; 34(4):888-92. DOI: 10.1111/j.1471-4159.1980.tb09662.x. View

5.
Wajda I, Banay-Schwartz M, Manigault I, Lajtha A . Effect of lithium and sodium ions on opiate- and dopamine-receptor binding. Neurochem Res. 1981; 6(3):321-31. DOI: 10.1007/BF00964047. View